Multi-variant vaccine study opens at King's CRF
A new vaccine study which will assess the safety and efficacy of a vaccine will will target multiple variants of the COVID-19-causing Sars-CoV-2 virus - including the current dominant variant Omicron.
By NIHR Wellcome King's Clinical Research Facility at 13 Apr 2022